Stockscreener 앱 받기
1.03
1.90%
-0.02
시장 영업 전:
1.07
0.04
+3.88%
전일 마감가:
$1.05
열려 있는:
$1.05
하루 거래량:
771.86K
Relative Volume:
0.94
시가총액:
$196.48M
수익:
$4.71M
순이익/손실:
$-58.01M
주가수익비율:
-1.2509
EPS:
-0.8234
순현금흐름:
$-46.68M
1주 성능:
-3.74%
1개월 성능:
+0.00%
6개월 성능:
-2.83%
1년 성능:
-32.24%
1일 변동 폭
$1.025
$1.07
1주일 범위
$1.025
$1.12
52주 변동 폭
$0.90
$1.6293
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.03 | 200.30M | 4.71M | -58.01M | -46.68M | -0.8234 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
LUCD - Finviz
LUCD News | LUCID DIAGNOSTICS INC (NASDAQ:LUCD) - ChartMill
Director buys 245K Lucid Diagnostics (NASDAQ: LUCD) shares in market - Stock Titan
Lucid Diagnostics Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LUCD) 2026-05-17 - Seeking Alpha
Lucid Diagnostics Inc. (LUCD) reports Q1 loss, misses revenue estimates - MSN
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... By GuruFocus - Investing.com Canada
Upcoming Events - FinancialContent
Maxim Group Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Cuts Target Price to $2 - Moomoo
BTIG Maintains Lucid Diagnostics(LUCD.US) With Buy Rating, Maintains Target Price $2.5 - Moomoo
PAVmed (PAVM) Q1 2026 Earnings Transcript - AOL.com
PAVmed (PAVM) Q4 2025 Earnings Transcript - The Globe and Mail
PAVmed Reports Q1 2026 Financial Results, Highlights Progress in Veris Health FDA Submission and Lucid Diagnostics Commercial Expansion - Minichart
Earnings Call Summary | Lucid Diagnostics(LUCD.US) Q1 2026 Earnings Conference - 富途牛牛
PAVmed Reports Wider-than-Expected Q1 2026 Loss - AlphaStreet
Earnings call transcript: PAVmed Inc. Q1 2026 shows restructuring gains By Investing.com - Investing.com Australia
Q1 2026 PAVmed Inc Earnings Call Transcript - GuruFocus
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2026 Earnings Call Transcript - Insider Monkey
PAVmed (NASDAQ: PAVM) Q1 2026 results, losses and cash position - Stock Titan
PAVmed Q1: cancer test and implantable monitor push toward coverage, FDA - Stock Titan
Canaccord Genuity Sticks to Its Buy Rating for Lucid Diagnostics (LUCD) - The Globe and Mail
Lucid says $44.8M pro forma cash extends runway well into 2027 as it awaits Medicare LCD - MSN
Lucid Diagnostics Inc.Common Stock (NQ: LUCD - FinancialContent
PAVmed Inc.Series Z Warrant (NQ: PAVMZ - FinancialContent
Lucid Diagnostics Earnings Call Balances Progress, Pressure - TipRanks
PAVmed Reports Business Expansion and Financial Update - Intellectia AI
PAVmed (NASDAQ: PAVM) posts Q1 2026 loss and flags going concern risks - Stock Titan
Lucid Diagnostics Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Lucid Diagnostics Releases Q1 2026 Financial Results - AlphaStreet
LUCD Q1 2026 Earnings Transcript - The Globe and Mail
Lucid Diagnostics Q1 Earnings Call Highlights - Yahoo Finance
LUCD: Q1 revenue reached $1.3M on 3,177 tests, with cash runway extended and Medicare approval pending - TradingView
Lucid Diagnostics Reports Q1 2026 Financial Results: $1.3M Revenue, Strong Cash Position, and Medicare Reimbursement Milestone Progress - Minichart
Earnings call transcript: Lucid Diagnostics Q1 2026: Revenue Miss Despite EPS Match - Investing.com
LUCD: Q1 2026 delivered strong test volume, improved cash, and progress toward Medicare and VA revenue - TradingView
Lucid Diagnostics earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Lucid Diagnostics Reports Q1 2026 Results and Outlook - TipRanks
LUCID DIAGNOSTICS ($LUCD) Releases Q1 2026 Earnings - Quiver Quantitative
Lucid Diagnostics (NASDAQ: LUCD) narrows loss and extends cash runway into 2027 - Stock Titan
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results - marketscreener.com
Lucid Diagnostics Inc (LUCD) Q1 2026 Earnings Call Highlights: Exceeding Test Targets and ... By GuruFocus - Investing.com Canada
Lucid Diagnostics 1Q 2026: Revenue $1.26M, EPS ($0.17) — 10-Q Summary - TradingView
LUCD: Q1 2026 saw higher revenue but continued losses, with future viability hinging on reimbursement and capital - TradingView
Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Lucid Diagnostics (NASDAQ: LUCD) grows Q1 revenue but flags going-concern risk - Stock Titan
TradingKey - TradingKey
Fat Pitch FinancialsLucid Diagnostics Inc.Common Stock (Nasdaq:LUCD) Stock Quote - FinancialContent
Lucid Diagnostics Inc. (LUCD) may report negative earnings: Know the trend ahead of next week's release - MSN
Lucid Diagnostics (NASDAQ:LUCD) Stock Rating Lowered by Wall Street Zen - MarketBeat
Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Lucid Diagnostics (LUCD) to Release Earnings on Thursday - MarketBeat
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):